Capping Of Coronary Stent Prices In India Is ‘Deeply Disappointing,’ Says US Medtech Body

The Indian government has fixed the maximum price that can be charged for coronary stents for a year in an attempt to make treatments more affordable. US medtech companies say, however, that a singular focus on pricing is misguided and that steps should be taken to fix “inefficiencies” in the health-care ecosystem.